| A microfluidic 3D in vitro model for specificity of breast cancer metastasis to bone S Bersini, JS Jeon, G Dubini, C Arrigoni, S Chung, JL Charest, M Moretti, ... Biomaterials 35 (8), 2454-2461, 2014 | 563 | 2014 |
| Human in vitro 3D co-culture model to engineer vascularized bone-mimicking tissues combining computational tools and statistical experimental approach S Bersini, M Gilardi, C Arrigoni, G Talò, M Zamai, L Zagra, V Caiolfa, ... Biomaterials 76, 157-172, 2016 | 83 | 2016 |
| Bioprinting and organ-on-chip applications towards personalized medicine for bone diseases C Arrigoni, M Gilardi, S Bersini, C Candrian, M Moretti Stem cell reviews and reports 13, 407-417, 2017 | 63 | 2017 |
| Rotating versus perfusion bioreactor for the culture of engineered vascular constructs based on hyaluronic acid C Arrigoni, A Chittò, S Mantero, A Remuzzi Biotechnology and bioengineering 100 (5), 988-997, 2008 | 63 | 2008 |
| Sound-induced morphogenesis of multicellular systems for rapid orchestration of vascular networks D Petta, V Basoli, D Pellicciotta, R Tognato, J Barcik, C Arrigoni, ... Biofabrication 13 (1), 015004, 2020 | 47 | 2020 |
| In vitro co-culture models of breast cancer metastatic progression towards bone C Arrigoni, S Bersini, M Gilardi, M Moretti International journal of molecular sciences 17 (9), 1405, 2016 | 45 | 2016 |
| Oncogenic hijacking of a developmental transcription factor evokes vulnerability toward oxidative stress in Ewing sarcoma A Marchetto, S Ohmura, MF Orth, MML Knott, MV Colombo, C Arrigoni, ... Nature communications 11 (1), 2423, 2020 | 43 | 2020 |
| Advanced microfluidic models of cancer and immune cell extravasation: a systematic review of the literature C Mondadori, M Crippa, M Moretti, C Candrian, S Lopa, C Arrigoni Frontiers in bioengineering and biotechnology 8, 907, 2020 | 40 | 2020 |
| Organs-on-a-chip as model systems for multifactorial musculoskeletal diseases C Arrigoni, S Lopa, C Candrian, M Moretti Current opinion in biotechnology 63, 79-88, 2020 | 40 | 2020 |
| Tackling muscle fibrosis: from molecular mechanisms to next generation engineered models to predict drug delivery S Bersini, M Gilardi, M Mora, S Krol, C Arrigoni, C Candrian, S Zanotti, ... Advanced drug delivery reviews 129, 64-77, 2018 | 37 | 2018 |
| Vascular tissue engineering C Arrigoni, D Camozzi, A Remuzzi Cell transplantation 15 (1_suppl), 119-125, 2006 | 37 | 2006 |
| The effect of sodium ascorbate on the mechanical properties of hyaluronan-based vascular constructs C Arrigoni, D Camozzi, B Imberti, S Mantero, A Remuzzi Biomaterials 27 (4), 623-630, 2006 | 34 | 2006 |
| Rational design of prevascularized large 3D tissue constructs using computational simulations and biofabrication of geometrically controlled microvessels C Arrigoni, M Bongio, G Talò, S Bersini, J Enomoto, J Fukuda, M Moretti Advanced healthcare materials 5 (13), 1617-1626, 2016 | 31 | 2016 |
| A microphysiological early metastatic niche on a chip reveals how heterotypic cell interactions and inhibition of integrin subunit β 3 impact breast cancer cell extravasation M Crippa, S Bersini, M Gilardi, C Arrigoni, S Gamba, A Falanga, ... Lab on a Chip 21 (6), 1061-1072, 2021 | 29 | 2021 |
| Engineered miniaturized models of musculoskeletal diseases S Bersini, C Arrigoni, S Lopa, M Bongio, I Martin, M Moretti Drug discovery today 21 (9), 1429-1436, 2016 | 28 | 2016 |
| Direct but not indirect co-culture with osteogenically differentiated human bone marrow stromal cells increases RANKL/OPG ratio in human breast cancer cells generating bone … C Arrigoni, P De Luca, M Gilardi, S Previdi, M Broggini, M Moretti Molecular Cancer 13, 1-6, 2014 | 28 | 2014 |
| Umbilical cord MSCs and their secretome in the therapy of arthritic diseases: a research and industrial perspective C Arrigoni, D D’Arrigo, V Rossella, C Candrian, V Albertini, M Moretti Cells 9 (6), 1343, 2020 | 25 | 2020 |
| Engineering complex muscle-tissue interfaces through microfabrication C Arrigoni, D Petta, S Bersini, V Mironov, C Candrian, M Moretti Biofabrication 11 (3), 032004, 2019 | 22 | 2019 |
| Industrialization of a perfusion bioreactor: Prime example of a non‐straightforward process G Talò, C Turrisi, C Arrigoni, C Recordati, I Gerges, M Tamplenizza, ... Journal of Tissue Engineering and Regenerative Medicine 12 (2), 405-415, 2018 | 15 | 2018 |
| Characterization of articular chondrocytes isolated from 211 osteoarthritic patients M Lagana, C Arrigoni, S Lopa, V Sansone, L Zagra, M Moretti, ... Cell and tissue banking 15, 59-66, 2014 | 15 | 2014 |
matteo morettiRegenerative Medicine Technologies Lab, Ente Ospedaliero Cantonale, Lugano, CH在 eoc.ch 的电子邮件经过验证
